🔗 Share this article

Treasury head Rachel Reeves has announced she is planning "focused measures to deal with cost of living challenges" in next month's financial statement.

Speaking to media outlets, she stated that lowering price rises is a collective responsibility of both the government and the central bank.

The United Kingdom's inflation rate is projected to be the highest among the Group of Seven industrialized countries this calendar year and the following year.

Possible Utility Cost Interventions

Reports indicate the government could intervene to lower utility costs, such as by cutting the present 5% rate of value-added tax applied on energy.

An additional possibility is to lower some of the policy costs currently added to bills.

Budgetary Limitations and Expert Predictions

The government will receive the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much space there is for such measures.

The expectation from most analysts is that the Chancellor will have to declare tax rises or expenditure reductions in order to meet her voluntary borrowing rules.

Previously on Thursday, calculations suggested there was a £22 billion gap for the Treasury chief to resolve, which is at the lower end of forecasts.

"It is a shared responsibility between the Bank of England and the administration to bear down further on some of the drivers of inflation," the Chancellor informed reporters in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Pledges and Global Issues

While a great deal of the focus has been on likely tax rises, the Treasury chief said the most recent data from the fiscal watchdog had not altered her vow to election pledges not to raise rates on earnings tax, sales tax or National Insurance.

She attributed an "uncertain global environment" with rising international and trade tensions for the Budget tax moves, likely to be targeted on those "with the broadest shoulders."

Global Trade Tensions

Referring to concerns about the UK's commercial links with the Asian nation she said: "The UK's national security invariably come first."

Last week's statement by China to strengthen trade restrictions on critical minerals and other resources that are key for advanced tech manufacturing led American leader Donald Trump to propose an extra 100% tariff on goods from China, increasing the risk of an all-out trade war between the two economic giants.

The US Treasury Secretary called the Chinese move "economic coercion" and "a global supply chain control attempt."

Asked about considering the American proposal to participate in its dispute with China, the Chancellor said she was "extremely troubled" by Chinese measures and urged the Beijing authorities "not to put up barriers and restrict access."

She said the action was "harmful for the international commerce and creates further challenges."

"I believe there are sectors where we need to address Chinese policies, but there are also significant chances to export to Chinese markets, including banking sector and other sectors of the economy. We've got to achieve that balance appropriate."

The Treasury chief also stated she was working with international partners "regarding our own critical minerals strategy, so that we are less reliant."

NHS Drug Costs and Funding

Reeves also admitted that the cost the National Health Service pays for pharmaceuticals could rise as a consequence of current discussions with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and capital.

A number of the biggest global pharmaceutical manufacturers have said lately that they are either halting or canceling investments in the United Kingdom, with several blaming the modest returns they are obtaining.

Recently, the government science advisor said the cost the health service pays for drugs would have to increase to prevent businesses and drug research funding leaving the UK.

The Chancellor told the BBC: "We have seen due to the cost structure, that medical research, innovative medicines have not been provided in the UK in the extent that they are in other continental states."

"The objective is to guarantee that patients receiving care from the NHS are can obtain the best life-saving medicines in the globe. And so we are looking at this situation, and... aiming to attract additional capital into Britain."